Chronic active hepatitis: immunopathogenesis and immunotherapy.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Israel journal of medical sciences

• Publication date

  1979-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 378898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease.

  1978cited by this paper
• Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability.

  1978cited by this paper
• Lymphocyte cytotoxicity in chronic active hepatitis: effect of therapy and correlations with clinical and histological changes.

  1978cited by this paper
• Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

  1978cited by this paper
• Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon.

  1978cited by this paper
• Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome

  1977cited by this paper
• Fibroblast interferon in HBsAg-positive chronic active hepatitis.

  1977cited by this paper
• Antiviral activity of interferons.

  1977cited by this paper
• Genetically determined immune hyperreactivity in human liver disease.

  1977cited by this paper
• Levamisole in viral hepatitis.

  1977cited by this paper
• Controlled trial of synthetic D-penicillamine and prednisone in maintenance therapy for active chronic hepatitis.

  1977cited by this paper
• Administration of human fibroblast interferon in chronic hepatitis-B infection.

  1976cited by this paper
• Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.

  1976cited by this paper
• Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

  1976cited by this paper
• Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

  1976cited by this paper
• Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.

  1976cited by this paper
• Failure of customary treatment in chronic active liver disease: causes and management.

  1976cited by this paper
• Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting.

  1976cited by this paper
• Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer.

  1976cited by this paper
• Autoimmune reaction to a liver specific membrane antigen during acute viral hepatitis.

  1976cited by this paper
• Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients.

  1975cited by this paper
• Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

  1975cited by this paper
• Interferon.

  1975cited by this paper
• Chromosomal localization of human genes governing the interferon-induced antiviral state.

  1975cited by this paper
• Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

  1974cited by this paper
• Chronic active liver disease reexamined: prognosis hopeful.

  1974cited by this paper
• Histocompatibility Antigens in Active Chronic Hepatitis and Primary Biliary Cirrhosis

  1974cited by this paper
• Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes.

  1974cited by this paper
• Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.

  1973cited by this paper
• Infusion of hepatitis-B antibody in antigen-positive active chronic hepatitis.

  1973cited by this paper
• Controlled trial of prednisone and azathioprine in active chronic hepatitis.

  1973cited by this paper
• Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

  1972cited by this paper
• Association of autoimmune active chronic hepatitis with HL-A1,8.

  1972cited by this paper
• "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease.

  1972cited by this paper
• Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

  1972cited by this paper
• Raised antibody titres to measles and rubella viruses in chronic active hepatitis.

  1972cited by this paper
• Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

  1971cited by this paper
• Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

  1971cited by this paper

• Relationship of reduced suppressor T lymphocyte activity to the delayed healing of acute viral hepatitis

  2009cites this paper
• Seroimmunologic Classification of Chronic Hepatitis in 57 Children

  2007cites this paper
• Chronic Active Hepatitis: The Challenge for a New Nomenclature

  1993cites this paper
• Prognostic features and role of liver transplantation in severe corticosteroid‐treated autoimmune chronic active hepatitis

  1992cites this paper
• Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis.

  1991cites this paper
• Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis.

  1990cites this paper
• Auto‐immune chronic active hepatitis: A specific entity? The negative argument *

  1990cites this paper
• Natural History, Clinical Features, and Treatment of Autoimmune Hepatitis

  1984cites this paper
• Immunotherapy of chronic active viral hepatitis B with propionibacterium granulosum.

  1984cites this paper
• Liver abnormalities in patients with lichen planus. A retrospective case-control study.

  1984cites this paper
• [Cytotoxic activity of the lymphocytes in patients with chronic hepatitis and liver cirrhosis].

  1983cites this paper
• [Hepatological aspects of Sjögren's disease and syndrome].

  1982cites this paper
• A proposed role for the immune system in the pathogenesis of hepatitis B virus induced liver disease.

  1981cites this paper
• Theimunopathogenesis of cronic HBV inducedliver disease

  1981cites this paper
• [Therapy of chronic hepatitis].

  1980cites this paper
• Down to earth at Newcastle.

  1980cites this paper
• Chronic active hepatitis.

  1980cites this paper